NCT04927598View on ClinicalTrials.gov

Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

October 15, 2021

Study Completion Date

April 1, 2022

Conditions
Guillain-Barre Syndrome
Interventions
DEVICE

plasmapheresis

patients of Gullian Barrie syndrome undergo plasmapharesis

Trial Locations (1)

Unknown

Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04927598 - Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome | Biotech Hunter | Biotech Hunter